Q-omics provides the consensus-scored RPS15P5 profile across patient tissues and cancer cell-line models. RPS15P5 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, RPS15P5 is differentially expressed in 9, with the highest sampling consensus in COAD. Additionally, RPS15P5 RNA expression shows 16,251 significant gene co-expression associations, with the highest sampling consensus in DLBC. Together, these results highlight ACC, COAD, and DLBC as cancer lineages where RPS15P5 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPS15P5 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPS15P5 survival associations across molecular data types. RPS15P5 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPS15P5 RNA expression–survival associations across cancer types. High RPS15P5 expression shows unfavorable associations in ACC, LIHC, KIRP, UCEC and UCS, but favorable associations in CESC. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for RPS15P5 RNA expression.
This table summarizes RPS15P5 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for RPS15P5. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPS15P5 shows higher tumor expression in COAD, KIRC, LIHC, CHOL, KICH and LUSC. The COAD box plot shows higher RPS15P5 RNA expression in tumor versus normal tissue (log2 FC = +1.028, t-test p < 0.001).
This table shows molecular features associated with RPS15P5 in patient tissues and cancer cell lines. In patient samples, RPS15P5 shows the broadest associations at the RNA and protein expression levels, with DLBC recurring as the lineage with the largest associated feature set.
